Cristina Velázquez-Marrero
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Large-Conductance Calcium-Activated Potassium Channels | 4 | 2024 | 22 | 2.020 |
Why?
|
| Calcium | 8 | 2024 | 480 | 1.690 |
Why?
|
| Ethanol | 5 | 2024 | 192 | 1.570 |
Why?
|
| Presynaptic Terminals | 3 | 2020 | 53 | 1.220 |
Why?
|
| Pituitary Gland, Posterior | 5 | 2014 | 7 | 1.080 |
Why?
|
| Central Nervous System Depressants | 2 | 2016 | 37 | 0.940 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 2 | 2020 | 5 | 0.750 |
Why?
|
| Neuropeptides | 1 | 2020 | 59 | 0.700 |
Why?
|
| MicroRNAs | 1 | 2024 | 426 | 0.640 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channel beta Subunits | 2 | 2014 | 5 | 0.620 |
Why?
|
| Receptors, Opioid, mu | 3 | 2014 | 55 | 0.580 |
Why?
|
| beta Catenin | 1 | 2016 | 48 | 0.560 |
Why?
|
| Ryanodine | 1 | 2014 | 4 | 0.480 |
Why?
|
| Analgesics, Opioid | 3 | 2014 | 197 | 0.450 |
Why?
|
| Synapses | 2 | 2010 | 180 | 0.420 |
Why?
|
| Rats | 8 | 2020 | 3483 | 0.410 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 360 | 0.410 |
Why?
|
| Nonlinear Dynamics | 1 | 2011 | 33 | 0.380 |
Why?
|
| Receptors, Opioid, kappa | 1 | 2010 | 22 | 0.380 |
Why?
|
| Ion Channel Gating | 1 | 2011 | 83 | 0.380 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2020 | 1618 | 0.370 |
Why?
|
| Calcium Channels | 1 | 2010 | 76 | 0.360 |
Why?
|
| Action Potentials | 2 | 2012 | 231 | 0.350 |
Why?
|
| Neurons | 5 | 2016 | 1175 | 0.330 |
Why?
|
| Up-Regulation | 1 | 2011 | 513 | 0.310 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 3 | 2014 | 17 | 0.240 |
Why?
|
| 3' Untranslated Regions | 1 | 2024 | 74 | 0.230 |
Why?
|
| Animals | 10 | 2020 | 15081 | 0.230 |
Why?
|
| Protein Isoforms | 1 | 2024 | 130 | 0.230 |
Why?
|
| Phosphorylation | 2 | 2016 | 928 | 0.210 |
Why?
|
| Calcium Channels, N-Type | 2 | 2012 | 6 | 0.200 |
Why?
|
| Kidney | 1 | 2024 | 337 | 0.200 |
Why?
|
| Oxytocin | 2 | 2012 | 25 | 0.190 |
Why?
|
| Time Factors | 3 | 2015 | 1742 | 0.180 |
Why?
|
| Glycogen Synthase Kinases | 1 | 2016 | 1 | 0.140 |
Why?
|
| Drug Tolerance | 1 | 2016 | 40 | 0.140 |
Why?
|
| Point Mutation | 1 | 2016 | 93 | 0.140 |
Why?
|
| Mice | 3 | 2020 | 5913 | 0.130 |
Why?
|
| Neuronal Plasticity | 1 | 2016 | 103 | 0.130 |
Why?
|
| Patch-Clamp Techniques | 3 | 2010 | 223 | 0.130 |
Why?
|
| Charybdotoxin | 1 | 2014 | 2 | 0.120 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2014 | 17 | 0.120 |
Why?
|
| Humans | 6 | 2024 | 37093 | 0.120 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2014 | 33 | 0.120 |
Why?
|
| Electrophysiology | 1 | 2014 | 136 | 0.120 |
Why?
|
| Vasopressins | 2 | 2012 | 13 | 0.120 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2014 | 73 | 0.120 |
Why?
|
| Potassium | 1 | 2014 | 112 | 0.120 |
Why?
|
| Nucleus Accumbens | 1 | 2014 | 82 | 0.120 |
Why?
|
| Amino Acid Sequence | 1 | 2016 | 1180 | 0.120 |
Why?
|
| Lipid Bilayers | 1 | 2014 | 68 | 0.120 |
Why?
|
| Synaptic Transmission | 2 | 2010 | 146 | 0.110 |
Why?
|
| Membrane Potentials | 2 | 2011 | 223 | 0.110 |
Why?
|
| Neurosecretion | 1 | 2012 | 1 | 0.100 |
Why?
|
| Nerve Endings | 1 | 2012 | 8 | 0.100 |
Why?
|
| Calcium Channels, L-Type | 1 | 2012 | 20 | 0.100 |
Why?
|
| Hippocampus | 1 | 2015 | 561 | 0.100 |
Why?
|
| DNA, Recombinant | 1 | 2011 | 17 | 0.100 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 2011 | 15 | 0.100 |
Why?
|
| RNA Splicing | 1 | 2011 | 40 | 0.100 |
Why?
|
| Cells, Cultured | 2 | 2015 | 1518 | 0.100 |
Why?
|
| 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 1 | 2010 | 7 | 0.100 |
Why?
|
| Exons | 1 | 2011 | 88 | 0.090 |
Why?
|
| Arginine Vasopressin | 1 | 2010 | 13 | 0.090 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2010 | 15 | 0.090 |
Why?
|
| Male | 5 | 2014 | 20025 | 0.090 |
Why?
|
| GTP-Binding Proteins | 1 | 2010 | 60 | 0.090 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2011 | 107 | 0.090 |
Why?
|
| Corpus Striatum | 1 | 2011 | 104 | 0.090 |
Why?
|
| Animals, Newborn | 1 | 2011 | 343 | 0.090 |
Why?
|
| Calcium Signaling | 2 | 2012 | 101 | 0.080 |
Why?
|
| Cell Survival | 1 | 2011 | 864 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 1 | 2011 | 1609 | 0.070 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2005 | 13 | 0.070 |
Why?
|
| Adenosine Triphosphate | 1 | 2005 | 196 | 0.060 |
Why?
|
| Hypothalamus | 1 | 2004 | 129 | 0.060 |
Why?
|
| Sphingomyelins | 1 | 2014 | 11 | 0.030 |
Why?
|
| Electrophysiological Phenomena | 1 | 2014 | 19 | 0.030 |
Why?
|
| Phosphatidylcholines | 1 | 2014 | 47 | 0.030 |
Why?
|
| Protein Transport | 1 | 2015 | 302 | 0.030 |
Why?
|
| Receptor Cross-Talk | 1 | 2012 | 17 | 0.030 |
Why?
|
| Feedback, Physiological | 1 | 2012 | 31 | 0.030 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2012 | 53 | 0.030 |
Why?
|
| Pregnancy | 1 | 2015 | 1549 | 0.020 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2005 | 61 | 0.020 |
Why?
|
| Caffeine | 1 | 2004 | 28 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2004 | 77 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 893 | 0.010 |
Why?
|
| Female | 1 | 2015 | 20969 | 0.010 |
Why?
|